首页 | 本学科首页   官方微博 | 高级检索  
检索        

东菱精纯克栓酶治疗TIA临床疗效观察
引用本文:祝玉岩,胡增杰,臧丽华,陈菊英.东菱精纯克栓酶治疗TIA临床疗效观察[J].中国组织工程研究与临床康复,1998(5).
作者姓名:祝玉岩  胡增杰  臧丽华  陈菊英
作者单位:大连大学医学院附属医院神经内科
摘    要:目的:为很好地治疗短暂性脑缺血(TIA),从而预防脑梗塞保持神经系统正常功能。方法:本文应用东菱精纯克栓酶(DF-521)治疗TIA患者30例,观察其临床疗效,并应用低分子右旋糖酐治疗TIA患者30例作为对照。结果:治疗组显效26例,有效2例,总有效率达93.3%,明显优于对照组。DF-521治疗可显著降低血浆纤维蛋白原含量,有作用快、疗效好、复发频率低、副作用少的特点。结论:DF-521是治疗TIA的理想药物,值得推广。

关 键 词:东菱精纯克栓酶  短暂性脑缺血发作

Observation of DF-521 clinical effects in treatment for TIA
Institution:Department of Neurology,The Affiliated Hospital of Medical College of Dalian University
Abstract:methods Using DF-521 to treat 30 patients with TIA,observe the clinical effects and take Dextran as control to treat 30 TIA patients.Result:The treatment group 26 cases got apparent effects,2 cases were effcetive the total effectivenes was 93.3% and was far more superior to the control.DF-521 treatment could obviously decrease the amount of fibrinogen in the blood plasma,got the characteristics of fast-fuction,long-lasting effects,low recurrent rate,and fewer side feects.Conclusion:DF-521 was the ideal drug for TIA treatment,and worthwhile to put into extensive use.
Keywords:DF-521  Transient ischemic attack(TIA)
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号